Literature DB >> 25369797

Brazilin Isolated from Caesalpinia sappan suppresses nuclear envelope reassembly by inhibiting barrier-to-autointegration factor phosphorylation.

Seong-Hoon Kim1, Ha-Na Lyu1, Ye Seul Kim1, Yong Hyun Jeon1, Wanil Kim1, Sangjune Kim1, Jong-Kwan Lim1, Ho Won Lee1, Nam-In Baek1, Kwan-Yong Choi1, Jaetae Lee1, Kyong-Tai Kim2.   

Abstract

To date, many anticancer drugs have been developed by directly or indirectly targeting microtubules, which are involved in cell division. Although this approach has yielded many anticancer drugs, these drugs produce undesirable side effects. An alternative strategy is needed, and targeting mitotic exit may be one alternative approach. Localization of phosphorylated barrier-to-autointegration factor (BAF) to the chromosomal core region is essential for nuclear envelope compartment relocalization. In this study, we isolated brazilin from Caesalpinia sappan Leguminosae and demonstrated that it inhibited BAF phosphorylation in vitro and in vivo. Moreover, we demonstrated direct binding between brazilin and BAF. The inhibition of BAF phosphorylation induced abnormal nuclear envelope reassembly and cell death, indicating that perturbation of nuclear envelope reassembly could be a novel approach to anticancer therapy. We propose that brazilin isolated from C. sappan may be a new anticancer drug candidate that induces cell death by inhibiting vaccinia-related kinase 1-mediated BAF phosphorylation.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25369797     DOI: 10.1124/jpet.114.218792

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Current Progress of Phytomedicine in Glioblastoma Therapy.

Authors:  Fahad Hassan Shah; Saad Salman; Jawaria Idrees; Fariha Idrees; Syed Turab Ali Shah; Abid Ali Khan; Bashir Ahmad
Journal:  Curr Med Sci       Date:  2021-01-11

2.  Crystal structure of human vaccinia-related kinase 1 in complex with AMP-PNP, a non-hydrolyzable ATP analog.

Authors:  Yeen Shian Ngow; Sreekanth Rajan; Hong Ye; Ho Sup Yoon
Journal:  Protein Sci       Date:  2018-12-20       Impact factor: 6.725

3.  Comparative Interactomes of VRK1 and VRK3 with Their Distinct Roles in the Cell Cycle of Liver Cancer.

Authors:  Namgyu Lee; Dae-Kyum Kim; Seung Hyun Han; Hye Guk Ryu; Sung Jin Park; Kyong-Tai Kim; Kwan Yong Choi
Journal:  Mol Cells       Date:  2017-09-20       Impact factor: 5.034

4.  DNA unchained: two assays to discover and study inhibitors of the DNA clustering function of barrier-to-autointegration factor.

Authors:  Michael Burger; Caroline Schmitt-Koopmann; Jean-Christophe Leroux
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

5.  Barrier-to-autointegration factor 1: A novel biomarker for gastric cancer.

Authors:  Junjun Li; Bingbing Hu; Lei Fang; Yang Gao; Shuai Shi; Haoyu He; Xiaomei Liu; Caijun Yuan
Journal:  Oncol Lett       Date:  2018-09-11       Impact factor: 2.967

6.  Interaction of obtusilactone B and related butanolide lactones with the barrier-to-autointegration factor 1 (BAF1). A computational study.

Authors:  Christian Bailly; Gérard Vergoten
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-09-22

7.  Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells.

Authors:  Seong-Hoon Kim; Hye Guk Ryu; Juhyun Lee; Joon Shin; Amaravadhi Harikishore; Hoe-Yune Jung; Hoe-Youn Jung; Ye Seul Kim; Ha-Na Lyu; Eunji Oh; Nam-In Baek; Kwan-Yong Choi; Ho Sup Yoon; Kyong-Tai Kim
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

8.  Roles of JNK/Nrf2 Pathway on Hemin-Induced Heme Oxygenase-1 Activation in MCF-7 Human Breast Cancer Cells.

Authors:  Hye-Yeon Jang; On-Yu Hong; Eun-Yong Chung; Kwang-Hyun Park; Jong-Suk Kim
Journal:  Medicina (Kaunas)       Date:  2020-05-29       Impact factor: 2.430

9.  Activity Screening of the Herb Caesalpinia sappan and an Analysis of Its Antitumor Effects.

Authors:  Yuan Li; Minghong Dong; Zijun Wu; Yongqi Huang; Haibing Qian; Cong Huang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-25       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.